Skip to content

MetLife (MET) — insider trading

Financials · NYSE

MetLife (MET) has 48 reported SEC Form 4 insider transactions in our data, including 1 open-market sale among the most recent 48 (latest 2026-10-01).

Recent Form 4 transactions

DateInsiderRoleTypeSharesPriceValueFiling
2026-10-01 Mumenthaler Christian Stephane Director Grant / award / vesting 544 $94.35 $51.3K Form 4
2026-10-01 Seitz Michelle Director Grant / award / vesting 544 — $0 Form 4
2026-10-01 WEINBERGER MARK A Director Grant / award / vesting 544 — $0 Form 4
2026-10-01 MCKENZIE DIANA Director Grant / award / vesting 544 $94.35 $51.3K Form 4
2026-10-01 Kennard William E Director Grant / award / vesting 544 $94.35 $51.3K Form 4
2026-10-01 Johnson Jeh C. Director Grant / award / vesting 544 $94.35 $51.3K Form 4
2026-10-01 Hay Laura J Director Grant / award / vesting 544 $94.35 $51.3K Form 4
2026-10-01 Harris Carla A Director Grant / award / vesting 544 $94.35 $51.3K Form 4
2026-10-01 HUBBARD ROBERT GLENN Director Grant / award / vesting 941 $94.35 $88.8K Form 4
2026-10-01 Glaser Daniel S Director Grant / award / vesting 544 $94.35 $51.3K Form 4
2026-09-08 Mumenthaler Christian Stephane Director Grant / award / vesting 21 $95.50 $2.0K Form 4
2026-09-08 TADROS RAMY Officer (President, U.S. Business) Grant / award / vesting 115 $95.50 $11.0K Form 4
2026-09-08 MCKENZIE DIANA Director Grant / award / vesting 157 $95.50 $15.0K Form 4
2026-09-08 Kennard William E Director Grant / award / vesting 294 $95.50 $28.1K Form 4
2026-09-08 Johnson Jeh C. Director Grant / award / vesting 59 $95.50 $5.6K Form 4
2026-09-08 Hay Laura J Director Grant / award / vesting 39 $95.50 $3.7K Form 4
2026-09-08 Harris Carla A Director Grant / award / vesting 42 $95.50 $4.0K Form 4
2026-09-08 HUBBARD ROBERT GLENN Director Grant / award / vesting 618 $95.50 $59.0K Form 4
2026-09-08 Glaser Daniel S Director Grant / award / vesting 10 $95.50 $955 Form 4
2026-08-31 TADROS RAMY Officer (President, U.S. Business) Shares withheld for taxes / exercise cost 4,366 $95.17 $415.5K Form 4
2026-08-31 DEBEL MARLENE Officer (EVP & Chief Risk Officer) Shares withheld for taxes / exercise cost 4,030 $95.17 $383.5K Form 4
2026-08-31 McCallion John D. Officer (EVP & Chief Financial Officer) Shares withheld for taxes / exercise cost 6,057 $95.17 $576.4K Form 4
2026-08-31 PAPPAS BILL Officer (EVP, Global Tech. & Ops.) Shares withheld for taxes / exercise cost 4,030 $95.17 $383.5K Form 4
2026-06-16 WEINBERGER MARK A Director Grant / award / vesting 587 — $0 Form 4
2026-06-16 Glaser Daniel S Director Grant / award / vesting 587 $87.40 $51.3K Form 4
2026-06-16 Seitz Michelle Director Grant / award / vesting 587 — $0 Form 4
2026-06-16 Harris Carla A Director Grant / award / vesting 587 $87.40 $51.3K Form 4
2026-06-16 HUBBARD ROBERT GLENN Director Grant / award / vesting 1,016 $87.40 $88.8K Form 4
2026-06-16 Hay Laura J Director Grant / award / vesting 587 $87.40 $51.3K Form 4
2026-06-16 MCKENZIE DIANA Director Grant / award / vesting 587 $87.40 $51.3K Form 4
2026-06-16 Johnson Jeh C. Director Grant / award / vesting 587 $87.40 $51.3K Form 4
2026-06-16 Kennard William E Director Grant / award / vesting 587 $87.40 $51.3K Form 4
2026-06-16 Mumenthaler Christian Stephane Director Grant / award / vesting 587 $87.40 $51.3K Form 4
2026-06-09 TADROS RAMY Officer (President, U.S. Business) Grant / award / vesting 127 $85.57 $10.9K Form 4
2026-06-09 HUBBARD ROBERT GLENN Director Grant / award / vesting 678 $85.57 $58.0K Form 4
2026-06-09 Glaser Daniel S Director Grant / award / vesting 7 $85.57 $599 Form 4
2026-06-09 Mumenthaler Christian Stephane Director Grant / award / vesting 20 $85.57 $1.7K Form 4
2026-06-09 Harris Carla A Director Grant / award / vesting 42 $85.57 $3.6K Form 4
2026-06-09 Johnson Jeh C. Director Grant / award / vesting 61 $85.57 $5.2K Form 4
2026-06-09 Hay Laura J Director Grant / award / vesting 39 $85.57 $3.3K Form 4
2026-06-09 Kennard William E Director Grant / award / vesting 322 $85.57 $27.6K Form 4
2026-06-09 MCKENZIE DIANA Director Grant / award / vesting 169 $85.57 $14.5K Form 4
2026-06-01 DEBEL MARLENE Officer (EVP & Chief Risk Officer) Option exercise / conversion (derivative) 10,712 — $0 Form 4
2026-06-01 DEBEL MARLENE Officer (EVP & Chief Risk Officer) Option exercise / conversion (derivative) 10,600 — $0 Form 4
2026-06-01 DEBEL MARLENE Officer (EVP & Chief Risk Officer) Open-market sale 21,312 $81.59 $1.74M Form 4
2026-06-01 DEBEL MARLENE Officer (EVP & Chief Risk Officer) Option exercise / conversion 10,712 $45.50 $487.4K Form 4
2026-06-01 DEBEL MARLENE Officer (EVP & Chief Risk Officer) Option exercise / conversion 10,600 $46.85 $496.6K Form 4
2026-04-30 O'Neill Adrienne Karen Officer (EVP & Chief Accounting Officer) Grant / award / vesting 12,485 — — Form 4

Ask the chat about MET's insider activity →

Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.

Source: SEC EDGAR Form 3/4/5. See the full company profile: MetLife (MET).

Last updated 2026-10-01 (most recent filing date).

Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.